| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 25.518 | 27.224 | 29.539 | 37.356 | 46.860 | 49.829 | 46.640 | 63.762 | 75.691 | 93.367 |
| Total Income - EUR | 25.829 | 27.301 | 29.558 | 37.395 | 47.029 | 50.025 | 49.083 | 64.374 | 75.847 | 93.667 |
| Total Expenses - EUR | 11.293 | 10.256 | 13.015 | 15.675 | 19.353 | 19.814 | 27.390 | 30.157 | 24.747 | 36.923 |
| Gross Profit/Loss - EUR | 14.536 | 17.045 | 16.543 | 21.720 | 27.675 | 30.211 | 21.693 | 34.216 | 51.100 | 56.744 |
| Net Profit/Loss - EUR | 13.761 | 16.499 | 16.248 | 21.347 | 27.207 | 29.911 | 21.241 | 33.615 | 50.356 | 53.991 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Dr. Schidu Ana S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 556 | 447 | 420 | 392 | 356 | 330 | 1.343 | 1.971 | 1.597 | 25.065 |
| Current Assets | 13.963 | 17.220 | 16.631 | 21.978 | 28.181 | 31.553 | 21.656 | 33.410 | 55.495 | 35.952 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.276 | 2.032 | 2.020 | 3.136 | 19.872 | 23.225 | 16.781 | 23.427 | 24.783 | 35.068 |
| Cash | 12.687 | 15.188 | 14.610 | 18.842 | 8.309 | 8.328 | 4.875 | 9.983 | 30.711 | 884 |
| Shareholders Funds | 13.811 | 16.548 | 16.296 | 21.394 | 27.253 | 29.956 | 21.294 | 33.669 | 50.410 | 54.044 |
| Social Capital | 49 | 49 | 48 | 47 | 46 | 45 | 44 | 45 | 44 | 44 |
| Debts | 708 | 1.119 | 754 | 976 | 1.349 | 1.991 | 1.769 | 1.776 | 6.682 | 7.154 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dr. Schidu Ana S.r.l.